High-performance multiplex drug-gated CAR circuits
Year: 2022
Type: article
Source: Cancer Cell
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: U.S. Department of Defense, Boston University, National Institutes of Health, Defense Advanced Research Projects Agency, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Biomedical Imaging and Bioengineering, National Center for Research Resources, Defense Sciences Office, DARPA
Awards: Combatting antibiotic resistance with synthetic biology technologies, G1915869239, G3565426627, Engineering a smart CAR platform for human regulatory T cells, G482346955, G5247627126, High Sensitivity In Vivo Imaging System with Integrated Micro-Computed Tomography for Animal Phenotyping Core, G7295355541, EPIGENETICALLY PROGRAMMED BIOLOGICAL MATERIALS, G8348780024, Synthetically Reengineered T cells as the Next Generation of Smart Cancer Therapy, In Vivo Imaging Analysis System - Xenogen IVIS Spectrum, Synthetic circuit technologies for precision control and signal processing in mammalian cells, Translational Research in Biomaterials, Precise tumor targeting with logic CAR circuits, Integrative Approaches for Probing Cell Mechanotransduction in Health and Disease
OpenAlex ID: W4296248317